M1a prostate cancer: Results of a Dutch multidisciplinary consensus meeting
Shafak Aluwini(Erasmus MC Cancer Institute), Daniela E. Oprea‐Lager(Amsterdam University Medical Centers), Niven Mehra(Royal Marsden NHS Foundation Trust), Henk G. van der Poel(Amsterdam University Medical Centers), Herman Stoevelaar(Barnes-Jewish Hospital), Derya Yakar(Dialyse Centrum Groningen), Hilda A. de Barros(The Netherlands Cancer Institute)
Cited by 11
Related Papers
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study
|The Lancet Oncology|2024|305
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis
|Clinical Cancer Research|2018|111
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)
|European Urology|2018|110
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
|Annals of the Rheumatic Diseases|2010|105
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
|Radiotherapy and Oncology|2022|98